Indian Pharmaceuticals Industry

According to a government notification, bulk drugs accounted for 63 per cent of total pharmaceutical imports in the country in 2018-19.

Updated On: 22 Jul 2020 | 8:10 PM IST

Pune's Serum Institute of India is placing its bets on the Oxford-AstraZeneca vaccine candidate AZD1222

Updated On: 22 Jul 2020 | 6:05 AM IST

A dozen of the 30 MPs, who are members of the parliamentary standing committee on home affairs, headed by Congress's Anand Sharma, attended the meeting

Updated On: 15 Jul 2020 | 9:15 PM IST

Some firms are now considering starting their own distribution centres in major cities

Updated On: 15 Jul 2020 | 6:05 AM IST

Union Cabinet on March 12 had approved scheme for development of three bulk drug and four medical device parks

Updated On: 13 Jul 2020 | 9:12 PM IST

Short-term disruptions include high input costs and various operational challenges.

Updated On: 07 Jul 2020 | 12:57 AM IST

On Thursday, CDSCO also approved Zydus Cadila's plasmid DNA vaccine candidate ZyCoV-D, developed at its Vaccine Technology Centre in Ahmedabad.

Updated On: 04 Jul 2020 | 2:30 AM IST

The total deal size thus will be around $500 mn or around Rs 3,750 crore

Updated On: 03 Jul 2020 | 10:05 AM IST

India supplies almost 20 per cent of the medicines consumed by the world. Every third tablet in the US market is from India

Updated On: 01 Jul 2020 | 10:54 PM IST

This comes after a week of economic disruption caused by introducing stringent scrutiny, resulting in shipments originating in China getting held up at Indian ports.

Updated On: 01 Jul 2020 | 3:45 AM IST

Indigenously developed Bharat Biotech's vaccine candidate Covaxin is entering human trials on Wednesday.

Updated On: 01 Jul 2020 | 3:10 AM IST

The second of a two-part series examines challenges linked to IPR and monopoly once Covid-19 vaccine is created

Updated On: 23 Jun 2020 | 1:01 AM IST

The public-private partnership trial-generated data will be soon presented before the country's drug regulator to see if it can get emergency-use authorisation.

Updated On: 22 Jun 2020 | 9:19 PM IST

Price and capacity constraints, however, would be big impediments.

Updated On: 20 Jun 2020 | 2:12 AM IST

Currently, the drug is allowed for "restricted emergency use" on severely ill hospitalised Covid patients in India.

Updated On: 19 Jun 2020 | 2:07 AM IST

Patient recruitment for the tocilizumab combination therapy study will begin this month.

Updated On: 10 Jun 2020 | 10:05 PM IST

Market research firm AIOCD AWACS has predicted zero growth in the domestic market this financial year.

Updated On: 09 Jun 2020 | 8:29 AM IST

Once touted as a 'wonder drug', HCQ has been battling global controversies around its safety and efficacy as a prophylactic against the new coronavirus SARS-CoV-2.

Updated On: 07 Jun 2020 | 1:14 AM IST

The USFDA granted remdesivir an emergency use authorization for the treatment of hospitalized patients with severe Covid-19

Updated On: 02 Jun 2020 | 10:43 PM IST

ICMR conducting study on presence of antibodies in people, results next week

Updated On: 29 May 2020 | 4:18 AM IST